Entecavir downregulates interleukin-37 in patients with chronic active hepatitis B infection

OBJECTIVES: Interleukin-37 (IL-37) has been identified as a potent inhibitor of the immune response. This study aimed to examine IL-37 expression in patients with chronic active hepatitis B (CAHB), and explore its possible regulatory role during inflammation. METHODS: Peripheral blood mononuclear ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jiang-Ping, Luo, Peng, Bai, Yao, Cui, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254606/
https://www.ncbi.nlm.nih.gov/pubmed/31939340
http://dx.doi.org/10.1177/0300060519884157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254606/
https://www.ncbi.nlm.nih.gov/pubmed/31939340
http://dx.doi.org/10.1177/0300060519884157

Ejemplares similares